UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 102

Sortiert nach

Risk Factors Associated With Complications and Mortality in Patients With Clostridium difficile Infection

Clinical infectious diseases, 2011-12, Vol.53 (12), p.1173-1178

2011

Link zum Volltext

Verfügbarkeit prüfen

Recruitment of a multi‐site randomized controlled trial of aerobic exercise for older adults with amnestic mild cognitive impairment: The EXERT trial

Alzheimer's & dementia, 2021-11, Vol.17 (11), p.1808-1817

2021

Link zum Volltext

Verfügbarkeit prüfen

A Phase I Pharmacokinetic and Pharmacodynamic Study of TKI258, an Oral, Multitargeted Receptor Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors

Clinical cancer research, 2008-04, Vol.14 (7), p.2075-2081

2008

Link zum Volltext

Verfügbarkeit prüfen

Repeated concussion among U.S. military personnel during Operation Iraqi Freedom

Journal of rehabilitation research and development, 2011-01, Vol.48 (10), p.1269-1278

2011

Link zum Volltext

Verfügbarkeit prüfen

A Phase I Study of the Combination of Intravenous Reovirus Type 3 Dearing and Gemcitabine in Patients with Advanced Cancer

Clinical cancer research, 2011-02, Vol.17 (3), p.581-588

2011

Link zum Volltext

Verfügbarkeit prüfen

EXERT: Impact of COVID‐19 on retention and intervention delivery of a large multisite exercise trial in adults with MCI

Alzheimer's & dementia, 2021-12, Vol.17 (S10), p.n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

A phase 1b/2, open-label, dose-escalation, and dose-confirmation study of eribulin mesilate in combination with capecitabine

British journal of cancer, 2019-03, Vol.120 (6), p.579-586

2019

Link zum Volltext

Verfügbarkeit prüfen

[P2–024]: EXERT: A PHASE 3 MULTI‐SITE RANDOMIZED CONTROLLED TRIAL OF AEROBIC EXERCISE IN MCI — STUDY DESIGN AND METHODS

Alzheimer's & dementia, 2017-07, Vol.13 (7S_Part_12)

2017

Link zum Volltext

Verfügbarkeit prüfen

EXERT: A PHASE 3 MULTI-SITE RANDOMIZED CONTROLLED TRIAL OF AEROBIC EXERCISE IN MCI — STUDY DESIGN AND METHODS

Alzheimer's & dementia, 2017-07, Vol.13 (7), p.P613-P613

2017

Link zum Volltext

Verfügbarkeit prüfen

A phase I/II study of Enadenotucirev, an oncolytic Ad11/Ad3 chimeric group B adenovirus, administered intraperitoneally (IP): Dose finding and proof of concept in platinum-resistant epithelial ovarian cancer

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.TPS5611-TPS5611

2015

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 multicenter, open-label study to establish the maximum tolerated dose (MTD) of two administration schedules of E7389 (eribulin) liposomal formulation in patients (pts) with solid tumors

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.2524-2524

2016

Link zum Volltext

Verfügbarkeit prüfen

Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin] : First member of a new class of chemotherapeutic agents-drug-polymer conjugates

Clinical cancer research, 1999, Vol.5 (1), p.83-94

1999

Link zum Volltext

Verfügbarkeit prüfen

Reply to Huttenen and Aittoniemi

Clinical infectious diseases, 2012-04, Vol.54 (8), p.1214-1215

2012

Link zum Volltext

Verfügbarkeit prüfen

Systematically searching for and assessing the literature for self-management of chronic pain: a lay users' perspective

BMC geriatrics, 2014-07, Vol.14 (1), p.86-86, Article 86

2014

Link zum Volltext

Verfügbarkeit prüfen

A phase I and pharmacokinetic study of capecitabine in combination with radiotherapy in patients with localised inoperable pancreatic cancer

Cancer chemotherapy and pharmacology, 2014-07, Vol.74 (1), p.131-139

2014

Link zum Volltext

Verfügbarkeit prüfen

A phase Ib dose-escalation study of eribulin mesylate in combination with capecitabine in patients with advanced/metastatic cancer

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.2552-2552

2012

Link zum Volltext

Verfügbarkeit prüfen

A Phase I Pharmacokinetic and Pharmacodynamic Study of TK1258, an Oral, Multitargeted Receptor Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors

Clinical cancer research, 2008, Vol.14 (7), p.2075-2081

2008

Link zum Volltext

Verfügbarkeit prüfen

One year, and counting, after publication of our ACS "Code of Professional Conduct"

Journal of the American College of Surgeons, 2004-11, Vol.199 (5), p.736

2004

Link zum Volltext

Verfügbarkeit prüfen

Phase I Clinical and Pharmacokinetic Study of PK1 [N-(2-Hydroxypropyl)methacrylamide Copolymer Doxorubicin]: First Member of a New Class of Chemotherapeutic AgentsâDrug-Polymer Conjugates

Clinical cancer research, 1999-01, Vol.5 (1), p.83

1999

Link zum Volltext

Verfügbarkeit prüfen

A follow-up study of the first 70 admissions to a general purpose adolescent unit

Journal of adolescence (London, England.), 1985-12, Vol.8 (4), p.333-345

1985

Link zum Volltext

Verfügbarkeit prüfen

A consumer survey of an adolescent unit

Journal of adolescence (London, England.), 1986-03, Vol.9 (1), p.63-72

1986

Link zum Volltext

Verfügbarkeit prüfen

Book reviews : Barham, P. and R. Howard (1991) From the Mental Patient to the Person. London, Routledge. 162 pp

International Social Work, 1993, Vol.36 (2), p.181-183

Morrison, Rosemary M.

1993

Link zum Volltext

Verfügbarkeit prüfen

'Approved' social worker

Journal - Royal Society of Health, 1979-10, Vol.99 (5), p.216

Morrison, R M

1979

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(83)

Publikationsform

Sprache

Englisch
(102)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Risk Factors Associated With Complications and Mortality in Patients With Clostridium difficile Infection

Recruitment of a multi‐site randomized controlled trial of aerobic exercise for older adults with amnestic mild cognitive impairment: The EXERT trial

A Phase I Pharmacokinetic and Pharmacodynamic Study of TKI258, an Oral, Multitargeted Receptor Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors

Repeated concussion among U.S. military personnel during Operation Iraqi Freedom

A Phase I Study of the Combination of Intravenous Reovirus Type 3 Dearing and Gemcitabine in Patients with Advanced Cancer

EXERT: Impact of COVID‐19 on retention and intervention delivery of a large multisite exercise trial in adults with MCI

A phase 1b/2, open-label, dose-escalation, and dose-confirmation study of eribulin mesilate in combination with capecitabine

Recruitment for a multi‐site randomized controlled trial of aerobic exercise for older adults with amnestic mild cognitive impairment: The EXERT trial: Prevention (nonpharmacological) / Exercise

Recruitment for a multi‐site randomized controlled trial of aerobic exercise for older adults with amnestic mild cognitive impairment: The EXERT trial

[P2–024]: EXERT: A PHASE 3 MULTI‐SITE RANDOMIZED CONTROLLED TRIAL OF AEROBIC EXERCISE IN MCI — STUDY DESIGN AND METHODS

EXERT: A PHASE 3 MULTI-SITE RANDOMIZED CONTROLLED TRIAL OF AEROBIC EXERCISE IN MCI — STUDY DESIGN AND METHODS

A phase I/II study of Enadenotucirev, an oncolytic Ad11/Ad3 chimeric group B adenovirus, administered intraperitoneally (IP): Dose finding and proof of concept in platinum-resistant epithelial ovarian cancer

Phase 1 multicenter, open-label study to establish the maximum tolerated dose (MTD) of two administration schedules of E7389 (eribulin) liposomal formulation in patients (pts) with solid tumors

Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin] : First member of a new class of chemotherapeutic agents-drug-polymer conjugates

Reply to Huttenen and Aittoniemi

Systematically searching for and assessing the literature for self-management of chronic pain: a lay users' perspective

A phase I and pharmacokinetic study of capecitabine in combination with radiotherapy in patients with localised inoperable pancreatic cancer

A phase Ib dose-escalation study of eribulin mesylate in combination with capecitabine in patients with advanced/metastatic cancer

A Phase I Pharmacokinetic and Pharmacodynamic Study of TK1258, an Oral, Multitargeted Receptor Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors

One year, and counting, after publication of our ACS "Code of Professional Conduct"

Phase I Clinical and Pharmacokinetic Study of PK1 [N-(2-Hydroxypropyl)methacrylamide Copolymer Doxorubicin]: First Member of a New Class of Chemotherapeutic AgentsâDrug-Polymer Conjugates

A follow-up study of the first 70 admissions to a general purpose adolescent unit

A consumer survey of an adolescent unit

Book reviews : Barham, P. and R. Howard (1991) From the Mental Patient to the Person. London, Routledge. 162 pp

'Approved' social worker

Suchergebnisse filtern